Search
Rislenemdaz
go.drugbank.com/drugs/DB12063InvestigationalMk 0657 has been used in trials studying the treatment of Major Depressive Disorder.
Categories: Receptors, N-Methyl-D-Aspartate, antagonists & inhibitorsDitiocarb zinc
go.drugbank.com/drugs/DB14193ApprovedDitiocarb zinc, also known as Diethyldithiocarbamic acid zinc salt, is a known chelator for copper and zinc. It also a dermatological sensitizer and allergen. Sensitivity to ditiocarb zinc may be identified with a clinical patch test.
Categories: Cytochrome P-450 CYP2A6 Inhibitors, Cytochrome P-450 CYP2E1 InhibitorsPotassium
go.drugbank.com/drugs/DB14500ApprovedInvestigationalPotassium is an essential nutrient, like Calcium and Magnesium. It was identified as a shortfall nutrient by the 2015-2020 Advisory Committee of Dietary Guidelines for Americans. Many conditions and diseases interfere with normal body po...
Mixtures: Liquid Opti-minplex +d, Multi Mega Minerals With Vitamin DCurcumin sulfate
go.drugbank.com/drugs/DB14635ExperimentalCategories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2B6 InhibitorsPrednisone acetate
go.drugbank.com/drugs/DB14646ApprovedInvestigationalWithdrawnCategories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 InducersClocortolone acetate
go.drugbank.com/drugs/DB14652ExperimentalCategories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 InducersNorethindrone enanthate
go.drugbank.com/drugs/DB14678InvestigationalCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesDextrorphan
go.drugbank.com/drugs/DB14682ExperimentalSynonyms: Levorphanol D-form, d-3-hydroxy-N-methylmorphinanCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesSpinosad
go.drugbank.com/drugs/DB08823ApprovedVet approvedSpinosad is a pediculicide mixture of spinosyn A and spinosyn D (in an approximately 5:1 ratio, respectively) used in the topical treatment of head lice in children (four years old and older) and in adults
Crizotinib
go.drugbank.com/drugs/DB08865ApprovedInvestigationalCrizotinib is a tyrosine kinase receptor inhibitor used for the treatment of anaplastic lymphoma kinase (ALK) or ROS1-positive non-small cell lung cancer (NSCLC) tumors, as well as ALK-positive anaplastic large cell lymphoma (ALCL) and i...
Categories: P-glycoprotein inhibitors, P-glycoprotein substrates